Experience

4P Pharma

• France
• Biotechnology Research
• 1 - 100 Employee

• CEO

  • Aug 2014 - Present

  4P-Pharma is an R&D focused company, licensing-in innovative therapeutics originated from highly competitive academic institutions following a selective/smart screening process and an efficient and cost-effective development plan. 4P Pharma expertise includes all the important management qualifications necessary for an early stage NCE development, from due diligence through to the first human clinical trial 4P-Pharma is an R&D focused company, licensing-in innovative therapeutics originated from highly competitive academic institutions following a selective/smart screening process and an efficient and cost-effective development plan. 4P Pharma expertise includes all the important management qualifications necessary for an early stage NCE development, from due diligence through to the first human clinical trial



4Moving-Biotech

• France
• Biotechnology Research

• Chairwoman

  • Jul 2020 - Present



4Living Biotech

• Chairwoman

  • Aug 2020 - Present



BIOSENIC S.A.

• Belgium
• Biotechnology Research
• 1 - 100 Employee

• Independant Board Member Biosenic

  • Oct 2022 - Present



Pharmaseed Europe

• Head of Pharmaseed Europe

  • Jan 2013 - Sep 2014

  Pharmaseed is Israel's largest GLP-certified pre-clinical CRO specializing in translational and regenerative studies.We have all the necessities for NCE, biologics and medical-device development to first-in-man trials such as safety evaluation in various animal models as well as complementary in-vitro/ex-vivo models and on-site human anatomy services.Our competence lies in the Pre-clinical projects, with large expertise in the following areas: Stem cell and cellular therapeutics, Angiogenesis, Cancer, Inflammation, CNS, Pain, Metabolic Disorders, Toxicology and Medical Devices.Pharmaseed opened in January 2013 a local European branch, located in Paris, France.



EndoStem, INSERM

• RTD European project coordinator

  • Jan 2010 - Sep 2014

• Post-doctoral fellowship

  • Mar 2007 - Dec 2009



AdSTEM

• United Kingdom
• Advertising Services

• CEO

  • Jan 2012 - Dec 2013

  AdSTEM is a biotherapeutic development company with a comprehensive product structure. AdSTEM’s patented technology is based on the discovery of a universal adult stem cell biomarker, which addresses the major challenges of the stem cell market by providing: • A small animal model that literally ‘lights up’ the rare stem cells in any tissue examined so that cell location and number can be rapidly followed in response to drugs undergoing pre- clinical testing. • A single-step method to purify stem cells from any adult tissue. Stem cells carry a patented biomarker that allows for their simple purification, and also tracks their stem cell competence over time. In parallel, we are developing a biotherapeutic agent that targets and activates adult stem cells without affecting non-stem cell populations. Presently, we are pursuing the development of this biotherapeutic with a specific focus on biodelivery for effective targeting to specific tissues including muscle, skin, brain and heart.